Evidence that zero antigen-matched cyclosporine- treated renal transplant recipients have graft survival equal to that of matched recipients

Stuart M. Greenstein, Richard S. Schechner, Pamela Louis, David Senitzer, Arthur Matas, Frank J. Veith, Vivian A. Tellis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The value of HLA matching in cadaver renal transplantation (CRT) continues to be debated. It has recently been suggested that increased importance be given to HLA matching for the distribution of cadaver kidneys. Such a policy would add both delay and expense to CRT, which could be justified only by significantly improved results. The results of CRT in 252 cyclosporine treated adult patients transplanted at our institution from November 1984 to April 1989 were reviewed. Kidneys were initially transplanted into crossmatch-negative recipients based on waiting time, regardless of match. From October 1987, a points system, based on United Network for Organ Sharing (UNOS) criteria has been used. Eighty-four pts. with zero antigen match with their donors were compared with 168 pts. sharing 1—6 Ag. Actuarial graft and patient survival were determined by the cumulative life table method and compared using a log rank test. Our results indicated no statistically significant difference in graft survival because of better matching or mismatching. These findings are in keeping with our previously reported long-term results for non-CsA pts. Past predictions of improved graft survival based upon better matching at our institution have not fulfilled expectations, with the exception of 6 Ag matches. In conclusion, increased emphasis on HLA matching with fewer “points” for poorer matches does not appear justifiable.

Original languageEnglish (US)
Pages (from-to)332-336
Number of pages5
JournalTransplantation
Volume49
Issue number2
StatePublished - 1990

Fingerprint

Graft Survival
Cadaver
Cyclosporine
Kidney Transplantation
Kidney
Antigens
Life Tables
Tissue Donors
Transplant Recipients

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Evidence that zero antigen-matched cyclosporine- treated renal transplant recipients have graft survival equal to that of matched recipients. / Greenstein, Stuart M.; Schechner, Richard S.; Louis, Pamela; Senitzer, David; Matas, Arthur; Veith, Frank J.; Tellis, Vivian A.

In: Transplantation, Vol. 49, No. 2, 1990, p. 332-336.

Research output: Contribution to journalArticle

Greenstein, SM, Schechner, RS, Louis, P, Senitzer, D, Matas, A, Veith, FJ & Tellis, VA 1990, 'Evidence that zero antigen-matched cyclosporine- treated renal transplant recipients have graft survival equal to that of matched recipients', Transplantation, vol. 49, no. 2, pp. 332-336.
Greenstein, Stuart M. ; Schechner, Richard S. ; Louis, Pamela ; Senitzer, David ; Matas, Arthur ; Veith, Frank J. ; Tellis, Vivian A. / Evidence that zero antigen-matched cyclosporine- treated renal transplant recipients have graft survival equal to that of matched recipients. In: Transplantation. 1990 ; Vol. 49, No. 2. pp. 332-336.
@article{6b4ae8e3ad0144d5ac03842adb5da08b,
title = "Evidence that zero antigen-matched cyclosporine- treated renal transplant recipients have graft survival equal to that of matched recipients",
abstract = "The value of HLA matching in cadaver renal transplantation (CRT) continues to be debated. It has recently been suggested that increased importance be given to HLA matching for the distribution of cadaver kidneys. Such a policy would add both delay and expense to CRT, which could be justified only by significantly improved results. The results of CRT in 252 cyclosporine treated adult patients transplanted at our institution from November 1984 to April 1989 were reviewed. Kidneys were initially transplanted into crossmatch-negative recipients based on waiting time, regardless of match. From October 1987, a points system, based on United Network for Organ Sharing (UNOS) criteria has been used. Eighty-four pts. with zero antigen match with their donors were compared with 168 pts. sharing 1—6 Ag. Actuarial graft and patient survival were determined by the cumulative life table method and compared using a log rank test. Our results indicated no statistically significant difference in graft survival because of better matching or mismatching. These findings are in keeping with our previously reported long-term results for non-CsA pts. Past predictions of improved graft survival based upon better matching at our institution have not fulfilled expectations, with the exception of 6 Ag matches. In conclusion, increased emphasis on HLA matching with fewer “points” for poorer matches does not appear justifiable.",
author = "Greenstein, {Stuart M.} and Schechner, {Richard S.} and Pamela Louis and David Senitzer and Arthur Matas and Veith, {Frank J.} and Tellis, {Vivian A.}",
year = "1990",
language = "English (US)",
volume = "49",
pages = "332--336",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Evidence that zero antigen-matched cyclosporine- treated renal transplant recipients have graft survival equal to that of matched recipients

AU - Greenstein, Stuart M.

AU - Schechner, Richard S.

AU - Louis, Pamela

AU - Senitzer, David

AU - Matas, Arthur

AU - Veith, Frank J.

AU - Tellis, Vivian A.

PY - 1990

Y1 - 1990

N2 - The value of HLA matching in cadaver renal transplantation (CRT) continues to be debated. It has recently been suggested that increased importance be given to HLA matching for the distribution of cadaver kidneys. Such a policy would add both delay and expense to CRT, which could be justified only by significantly improved results. The results of CRT in 252 cyclosporine treated adult patients transplanted at our institution from November 1984 to April 1989 were reviewed. Kidneys were initially transplanted into crossmatch-negative recipients based on waiting time, regardless of match. From October 1987, a points system, based on United Network for Organ Sharing (UNOS) criteria has been used. Eighty-four pts. with zero antigen match with their donors were compared with 168 pts. sharing 1—6 Ag. Actuarial graft and patient survival were determined by the cumulative life table method and compared using a log rank test. Our results indicated no statistically significant difference in graft survival because of better matching or mismatching. These findings are in keeping with our previously reported long-term results for non-CsA pts. Past predictions of improved graft survival based upon better matching at our institution have not fulfilled expectations, with the exception of 6 Ag matches. In conclusion, increased emphasis on HLA matching with fewer “points” for poorer matches does not appear justifiable.

AB - The value of HLA matching in cadaver renal transplantation (CRT) continues to be debated. It has recently been suggested that increased importance be given to HLA matching for the distribution of cadaver kidneys. Such a policy would add both delay and expense to CRT, which could be justified only by significantly improved results. The results of CRT in 252 cyclosporine treated adult patients transplanted at our institution from November 1984 to April 1989 were reviewed. Kidneys were initially transplanted into crossmatch-negative recipients based on waiting time, regardless of match. From October 1987, a points system, based on United Network for Organ Sharing (UNOS) criteria has been used. Eighty-four pts. with zero antigen match with their donors were compared with 168 pts. sharing 1—6 Ag. Actuarial graft and patient survival were determined by the cumulative life table method and compared using a log rank test. Our results indicated no statistically significant difference in graft survival because of better matching or mismatching. These findings are in keeping with our previously reported long-term results for non-CsA pts. Past predictions of improved graft survival based upon better matching at our institution have not fulfilled expectations, with the exception of 6 Ag matches. In conclusion, increased emphasis on HLA matching with fewer “points” for poorer matches does not appear justifiable.

UR - http://www.scopus.com/inward/record.url?scp=0025213551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025213551&partnerID=8YFLogxK

M3 - Article

VL - 49

SP - 332

EP - 336

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -